Pfizer Q2 Earnings Outlook - Search News

News

Pfizer, Q2

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.

Zacks Investment Research on M… · 1d

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.

Seeking Alpha on MSN · 2d

Pfizer rises as Q2 beat leads to guidance raise

Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year earnings outlook. Read more here.

5h

Pfizer's Turnaround Has Truly Started (Earnings Update)

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

2don MSN

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

GlobalData on MSN1d

Pfizer shares rise 3% after upping profit forecast for 2025

Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales ...

2d

Pfizer's tops Q2 on post-pandemic cost cuts, drug revenue

Pfizer (PFE) stock is moving higher after beating Wall Street expectations for the second quarter and raising its full-year ...

2d

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results